Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "metabolism"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
20
of
40
Search:
'"metabolism"'
,
query time: 0.12s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Clinical review report: Cysteamine 3.8 mg/mL ophthalmic solution (Cystadrops) (Recordati Rare Diseases Canada Inc.)
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cystine /
metabolism
...
”
Read Now
2
HbA1c testing frequency : review of the clinical evidence and guidelines
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Glycated Hemoglobin A /
metabolism
...
”
Read Now
3
Sapropterin dihydrochloride (Kuvan)
Published 2017
CADTH
“
...), is an autosomal recessive inborn error of
metabolism
caused by mutations in the gene encoding PAH, the enzyme...
”
Read Now
4
Sapropterin dihydrochloride (Kuvan)
Published 2017
CADTH
“
...), is an autosomal recessive inborn error of
metabolism
caused by mutations in the gene encoding PAH, the enzyme...
”
Read Now
5
Nitisinone (Orfadin) (Sobi Canada Inc.)
Published 2018
CADTH
Read Now
6
Clinical review report: Nitisinone (Nitisinone tablets) (Cycle pharmaceuticals ltd.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
7
Nitisinone (Orfadin) (Sobi Canada Inc.)
Published 2018
CADTH
Read Now
8
Increasing frequency of self-monitoring blood glucose test strips during pregnancy : a review of the clinical and cost-effectiveness and guidelines
by
Tran, Khai
,
Picheca, Lory
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... to or production of insulin, leading to the abnormal
metabolism
of sugar and increase in blood sugar level.1 Over...
”
Read Now
9
Clinical review report: Nitisinone (Nitisinone tablets) (Cycle pharmaceuticals ltd.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
10
Nitisinone (MDK-nitisinone) : (MendeliKABS inc.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
11
Increasing frequency of self-monitoring blood glucose test strips during pregnancy : a review of the clinical and cost-effectiveness and guidelines
by
Tran, Khai
,
Picheca, Lory
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... to or production of insulin, leading to the abnormal
metabolism
of sugar and increase in blood sugar level.1 Over...
”
Read Now
12
Glycerol phenylbutyrate (Ravicti)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
metabolism
, which can be life-threatening and result in permanent neurological damage if left untreated....
”
Read Now
13
Glycerol phenylbutyrate (Ravicti)
Published 2017
Canadian Agency for Drugs and Technologies in Health
Read Now
14
Nitisinone (MDK-nitisinone) : (MendeliKABS inc.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Read Now
15
Obesity management interventions delivered in primary care for patients with hypertension or cardiovascular disease : a review of clinical effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... desired changes without detrimental impact on vitamins and bone
metabolism
, and to determine...
”
Read Now
16
Obesity management interventions delivered in primary care for patients with hypertension or cardiovascular disease : a review of clinical effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
... desired changes without detrimental impact on vitamins and bone
metabolism
, and to determine...
”
Read Now
17
Clinical review report: Eliglustat (Cerdelga) : (Sanofi Genzyme) : indication: Gaucher disease type 1
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...1) who are cytochrome P450 2D6 (CYP2D6) poor
metabolizers
, intermediate
metabolizers
, or extensive...
”
Read Now
18
Clinical review report: Eliglustat (Cerdelga) : (Sanofi Genzyme) : indication: Gaucher disease type 1
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...1) who are cytochrome P450 2D6 (CYP2D6) poor
metabolizers
, intermediate
metabolizers
, or extensive...
”
Read Now
19
Pharmacoeconomic review report: Eliglustat (Cerdelga) : (Sanofi Genzyme) : indication: Gaucher disease type 1
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... disease type 1 (GD1) who are poor
metabolizers
, intermediate
metabolizers
, or extensive
metabolizers
...
”
Read Now
20
Clinical review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus
Published 2019
CADTH
“
...Diabetes mellitus is a
metabolic
disease that is characterized by persistent elevations in blood...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
38
380 - Commerce, communications & transportation
2
330 - Economics
1
Language
English
40
Collection
National Center for Biotechnology Information
40
Author
Canadian Agency for Drugs and Technologies in Health
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
2
Picheca, Lory
2
Tran, Khai
2
Recently Uploaded
Last Month
6
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22metabolism%22&type=AllFields
Send by Email
×
Loading...